Duloxetine Active Pharmaceutical Ingredients (API)
Market
Duloxetine Active Pharmaceutical Ingredients (API)
Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Duloxetine Active Pharmaceutical Ingredients (API) Market Size and Growth
The Duloxetine Active Pharmaceutical Ingredients (API) market is witnessing robust growth, driven by rising demand for antidepressants and anxiety treatments. The market size is estimated to reach approximately USD 1.5 billion by 2025, influenced by increasing healthcare investments and expanding therapeutic applications. Competitive landscapes are marked by significant R&D innovations. Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Teva Pharmaceutical Industries Ltd (Israel)
The Duloxetine API market features key players like Teva, Sun Pharma, and Eli Lilly, among others. These companies manufacture and supply Duloxetine, driving market growth through innovation and expanding production capabilities. Revenues include:
◍ Sun Pharmaceutical Industries Ltd (India)
◍ Aurobindo Pharma (India)
◍ Lupin (India)
◍ Zydus Cadila (India)
◍ Eli Lilly and Company (United States)
◍ Shodhana Laboratories (India)
◍ Hetero (India)
◍ Apotex (Canada)
◍ Shionogi (US)
- Teva: ~$16 billion
- Sun Pharma: ~$4.5 billion
- Aurobindo: ~$2 billion.
◍ Zhejiang Huahai Pharmaceutical (China)
Request Sample Report
Market Segmentation
By Application
By Product
Other ◍ Pharmaceutical and Biotechnology Industries
◍ Major Depression Drug
Hospital ◍ Other Request Sample Report
◍ Generalized Anxiety Disorder Drug ◍ Fibromyalgia Drugs ◍ Neuropathic Pain Medication
Market Growth
Request Sample Report
$ X Billion USD
